Indication
Aromatic L-amino acid decarboxylase deficiency
Aromatic L-amino acid decarboxylase deficiency is a rare, autosomal recessive inborn error of neurotransmitter metabolism caused by pathogenic variants in the *DDC* gene. Read more about Aromatic L-amino acid decarboxylase deficiency
1 drugs 1 manufacturers
Drugs that treat it
Common Aromatic L-amino acid decarboxylase deficiency therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAromatic L-amino acid decarboxylase deficiency is a rare, autosomal recessive inborn error of neurotransmitter metabolism caused by pathogenic variants in the *DDC* gene.
This enzymatic defect impairs the biosynthesis of essential biogenic amines, leading to a combined deficiency of catecholamines—specifically dopamine, norepinephrine, and epinephrine—as well as serotonin.
Primarily affecting the central and autonomic nervous systems, the condition typically manifests in early infancy with severe developmental delay, axial hypotonia, and characteristic paroxysmal movement disorders, most notably oculogyric crises and dystonia.
Affected individuals also frequently exhibit pervasive autonomic dysfunction, which can include temperature instability, excessive sweating, ptosis, nasal congestion, and blood pressure lability.
- medlineplus.gov
Aromatic L-amino acid decarboxylase deficiency is a rare, autosomal recessive inborn error of neurotransmitter metabolism caused by pathogenic variants in the *DDC* gene This enzymatic defect impairs the biosynthesis of essential biogenic amines, leading to a combined deficiency of catecholamines—specifically dopamine, norepinephrine, and epinephrine—as well as serotonin Primarily affecting the central and autonomic nervous systems, the condition typically manifests in early infancy with severe ...
- nih.gov
Aromatic L-amino acid decarboxylase deficiency is a rare, autosomal recessive inborn error of neurotransmitter metabolism caused by pathogenic variants in the *DDC* gene Primarily affecting the central and autonomic nervous systems, the condition typically manifests in early infancy with severe developmental delay, axial hypotonia, and characteristic paroxysmal movement disorders, most notably oculogyric crises and dystonia Affected individuals also frequently exhibit pervasive autonomic dysfunc...
- nih.gov
This enzymatic defect impairs the biosynthesis of essential biogenic amines, leading to a combined deficiency of catecholamines—specifically dopamine, norepinephrine, and epinephrine—as well as serotonin
Personalize your experience
Follow Aromatic L-amino acid decarboxylase deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.